SCHEMBL8273312

SCHEMBL8273312

Nc1ccccc1N1CCC(CNC(=O)[C@H](O)[C@@H](O)C(=O)N2CCC3(CCNCC3)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 6/20 0.41
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ ADAM10 O14672 1/20 0.35
▸ MMP12 P39900 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ OPRM1 P35372 1/20 0.32
▸ OPRL1 P41146 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ EIF4E P06730 1/20 0.32
▸ MKNK1 Q9BUB5 1/20 0.32
▸ MKNK2 Q9HBH9 1/20 0.32
▸ HTR4 Q13639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273584 0.88 NAMPT (0.37) ADAM17CYP2D6CYP3A4NAMPTUSP2
SCHEMBL8221040 0.88 ADAM17 (0.54) ADAM17CYP1A2CYP2D6CYP3A4NAMPT
SCHEMBL8274406 0.82 ADAM17 (0.49) ADAM17ADAM10MMP12MMP13MEN1
SCHEMBL8213705 0.80 ADAM17 (0.45) ADAM17CYP2D6CYP3A4NAMPTUSP2
SCHEMBL8273582 0.80 ADAM17 (0.47) ADAM17NAMPTADAM10MMP12MMP13
SCHEMBL8273741 0.78 ADAM17 (0.48) ADAM17MEN1USP2GAAKMT2A
SCHEMBL8275453 0.78 ADAM17 (0.44) ADAM17ADAM10MMP12MMP13MEN1
SCHEMBL8275600 0.75 ADAM17 (0.45) ADAM17NAMPTADAM10MMP12MMP13
SCHEMBL8273588 0.75 ADAM17 (0.40) ADAM17MEN1GAAKMT2AEIF4E
SCHEMBL8273443 0.75 DPP4 (0.41) ADAM17MEN1GAAKMT2AHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback